Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Brand Name
Terazosin Hydrochloride
Generic Name
Terazosin Hydrochloride
Active Ingredient
TerazosinCategory
Other
Salt Form
Hydrochloride
Variants
14
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Terazosin Hydrochloride, you must consult a qualified healthcare professional.
| 1 mg/1 | CAPSULE | ORAL | 68788-9817 |
| 2 mg/1 | CAPSULE | ORAL | 68788-9816 |
| 5 mg/1 | CAPSULE | ORAL | 71610-595 |
| 10 mg/1 | CAPSULE | ORAL | 71610-594 |
| 10 mg/1 | CAPSULE | ORAL | 71610-762 |
| 2 mg/1 | CAPSULE | ORAL | 71610-856 |
| 2 mg/1 | CAPSULE | ORAL | 71610-698 |
| 5 mg/1 | CAPSULE | ORAL | 71610-840 |
| 5 mg/1 | CAPSULE | ORAL | 68788-9815 |
+ 2 more variants
Detailed information about Terazosin Hydrochloride
Terazosin is an alpha-1 adrenergic antagonist used primarily to treat hypertension and benign prostatic hyperplasia (BPH). It works by relaxing smooth muscles in blood vessels and the prostate gland.
Dosage for Terazosin must be individualized and titrated (gradually increased) based on patient response to minimize the risk of severe hypotension (low blood pressure) and syncope (fainting).
Terazosin is not FDA-approved for use in pediatric patients. The safety and effectiveness of this medication in children have not been established. Healthcare providers generally avoid prescribing this medication to individuals under the age of 18.
In patients with renal insufficiency (kidney problems), the pharmacokinetic profile of Terazosin does not change significantly. Therefore, no specific dosage adjustment is typically required for patients with mild to moderate renal impairment. However, cautious monitoring is always advised.
Because Terazosin is metabolized in the liver and excreted via bile, patients with significant hepatic impairment (liver disease) should be treated with caution. Lower starting doses and slower titration may be necessary, as the drug may accumulate in the body.
Geriatric patients (those over 65) may be more sensitive to the hypotensive effects of Terazosin. There is an increased risk of dizziness and falls. Clinical trials suggest that while the efficacy is similar to younger adults, the titration should be performed with extra care.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular schedule. Do not double the dose to catch up. If you miss several days of Terazosin, do not restart at your maintenance dose. You must contact your doctor, as you may need to restart at the 1 mg 'starter' dose to avoid severe low blood pressure.
An overdose of Terazosin can lead to severe hypotension. Symptoms may include extreme dizziness, fainting, blurred vision, and a rapid or irregular heartbeat.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking the medication without medical guidance, as this could cause your blood pressure to spike or your BPH symptoms to return rapidly.
The most frequently reported side effects of Terazosin are related to its vasodilatory properties (widening of blood vessels). These are often most prominent during the first few days of treatment or when the dose is increased.
Terazosin is associated with a phenomenon known as the 'First-Dose Effect.' This refers to a sudden and significant drop in blood pressure that can lead to fainting (syncope), especially when the patient stands up. This effect is most likely to occur within 30 to 90 minutes after the very first dose, after a significant increase in dosage, or when restarting the medication after a break. To minimize this risk, the initial dose is strictly limited to 1 mg and should be taken at bedtime.
There are currently no FDA black box warnings for Terazosin. However, the risk of syncope is highlighted prominently in the 'Warnings' section of the official prescribing information.
There are few absolute contraindications for drug combinations with Terazosin, but the following require extreme caution:
Terazosin must NEVER be used in the following circumstances:
These are conditions where the drug should be used only if the benefits clearly outweigh the risks, and under strict medical supervision:
Terazosin is classified under FDA Pregnancy Category C. This means that animal reproduction studies have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies in humans.
It is not known whether Terazosin is excreted in human milk. Because many drugs are excreted in breast milk and because of the potential for serious adverse reactions in nursing infants (such as significantly low blood pressure), a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Terazosin is a selective antagonist of the alpha-1-adrenoceptor. At the molecular level, it binds to these receptors on the surface of smooth muscle cells. By occupying the receptor, it prevents the endogenous ligand, norepinephrine, from activating the G-protein coupled signaling pathway that leads to an increase in intracellular calcium. Without this calcium influx, the muscle fiber cannot contract, leading to relaxation. In the vasculature, this results in vasodilation. In the prostate gland, it results in the relaxation of the smooth muscle of the prostatic capsule and the bladder neck, reducing the 'dynamic' obstruction of urine.
Common questions about Terazosin Hydrochloride
Terazosin is primarily used to treat two distinct conditions: high blood pressure (hypertension) and benign prostatic hyperplasia (BPH). In patients with hypertension, it works by relaxing blood vessels so that blood can flow more easily through the body. For men with BPH, it relaxes the muscles in the prostate and the opening of the bladder, which helps make urination easier and less frequent. It is often prescribed to men who suffer from both conditions simultaneously. While it treats the symptoms of an enlarged prostate, it does not actually shrink the size of the prostate itself. Your doctor will determine the appropriate use based on your specific medical history and symptoms.
The most common side effects of Terazosin include dizziness, lightheadedness, headache, and a feeling of tiredness or weakness. Many patients also report nasal congestion (a stuffy nose) and somnolence (feeling sleepy). These side effects are most common when you first start the medication or when your doctor increases your dose. Most people find that these symptoms diminish over time as their body adjusts to the medicine. To minimize these effects, it is usually recommended to take the medication at bedtime. If these symptoms are severe or do not go away, you should consult your healthcare provider.
It is generally advised to avoid or strictly limit alcohol consumption while taking Terazosin. Alcohol acts as a vasodilator, meaning it relaxes your blood vessels, which is the same thing Terazosin does. When combined, this can lead to a dangerously large drop in blood pressure. This increases the risk of severe dizziness, fainting, and accidental falls or injuries. Even a small amount of alcohol can trigger these effects, especially during the first few weeks of treatment. Always talk to your doctor about your alcohol habits before starting this medication.
Terazosin is generally not recommended during pregnancy unless the potential benefits significantly outweigh the risks to the fetus. It is classified as FDA Category C, meaning animal studies have shown potential harm, but human data is lacking. There are other blood pressure medications that have a more established safety record for pregnant women. If you are taking Terazosin and discover you are pregnant, contact your doctor immediately to discuss your options. You should also consult your doctor if you are breastfeeding, as it is unknown if the drug passes into breast milk. Safety for the nursing infant is a primary concern.
The time it takes for Terazosin to work depends on the condition being treated. For high blood pressure, you may notice a decrease in your readings within 1 to 2 hours after the first dose. However, for benign prostatic hyperplasia (BPH), it usually takes longer to feel a difference in urinary symptoms. Most men notice an improvement in urine flow and frequency within 2 to 4 weeks of consistent use. It is important to keep taking the medication even if you do not feel an immediate change. Your doctor will likely start you on a low dose and gradually increase it over several weeks to reach the full effect.
You should not stop taking Terazosin suddenly without consulting your healthcare provider. If you stop the medication abruptly, your blood pressure may rise quickly, or your BPH symptoms may return. Furthermore, if you stop taking Terazosin for even a few days, you cannot simply restart at your previous dose. You would need to restart at the 1 mg 'starter' dose and gradually work your way back up to avoid a severe drop in blood pressure and fainting. Always talk to your doctor about a tapering schedule if you need to discontinue the medication. Consistency is key to the safe use of this drug.
If you miss a dose of Terazosin, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Never take two doses at once to make up for a missed one. If you miss your doses for several days in a row, do not take your next scheduled dose without calling your doctor first. You may need to restart the medication at a lower dose to prevent the 'first-dose effect' of low blood pressure. Keeping a daily routine or using a pill organizer can help you remember to take your medication consistently.
Weight gain is a possible, though not universal, side effect of Terazosin. This weight gain is typically not due to an increase in body fat, but rather due to fluid retention, also known as edema. Some patients notice swelling in their ankles, feet, or hands while taking the medication. If you notice a sudden or significant increase in weight over a few days, or if you experience swelling and shortness of breath, you should contact your doctor. This could be a sign that the medication is causing your body to hold onto too much fluid, which may need to be managed with a diuretic or a dose adjustment.
Terazosin can interact with several other medications, so it is vital to provide your doctor with a full list of everything you take. It is particularly important to mention other blood pressure drugs, as the combination can cause very low blood pressure. Erectile dysfunction medications like Viagra or Cialis are also a major concern, as they can cause a dangerous drop in pressure when combined with Terazosin. Even over-the-counter NSAIDs like ibuprofen can interfere with how well Terazosin works. Always consult your pharmacist or doctor before starting any new medication, supplement, or herbal product. They can check for potential interactions and ensure your safety.
Yes, Terazosin is widely available as a generic medication, which is typically much more affordable than brand-name versions. Generic Terazosin hydrochloride is bioequivalent to the original brand-name drug (Hytrin), meaning it has the same active ingredient, strength, and effectiveness. It is available in various capsule strengths, including 1 mg, 2 mg, 5 mg, and 10 mg. Most insurance plans and Medicare Part D programs cover generic Terazosin. If you have concerns about the cost of your medication, ask your pharmacist about the generic version. It is one of the most cost-effective options for treating BPH and hypertension.
Other drugs with the same active ingredient (Terazosin)
> Warning: Stop taking Terazosin and call your doctor immediately if you experience any of these serious symptoms:
With prolonged use, most patients develop a tolerance to the dizziness and lightheadedness associated with Terazosin. However, long-term use requires monitoring for:
No FDA black box warnings currently exist for Terazosin. However, the 'First-Dose Effect' is considered a major clinical warning that carries similar weight in prescribing practices. Healthcare providers are trained to emphasize the risk of syncope with the initial dose.
Report any unusual symptoms or side effects to your healthcare provider. Keeping a log of your blood pressure and any symptoms can help your doctor manage your treatment effectively.
Terazosin can cause significant drowsiness and dizziness. Patients should avoid driving, operating heavy machinery, or performing hazardous tasks for at least 24 hours after the first dose, after any dose increase, or if the medication is restarted after a hiatus.
Alcohol can potentiate (increase) the blood pressure-lowering effects of Terazosin. Drinking alcohol while taking this medication significantly increases the risk of dizziness, fainting, and falls. It is strongly recommended to limit or avoid alcohol consumption.
If Terazosin therapy is interrupted for more than a few days, the medication should not be restarted at the previous maintenance dose. Instead, the patient must return to the 1 mg initial dose and undergo the titration process again to prevent severe hypotension.
> Important: Discuss all your medical conditions, including any history of low blood pressure or heart disease, with your healthcare provider before starting Terazosin.
Terazosin is not known to significantly interfere with common laboratory tests, including those for blood glucose, cholesterol, or the Prostate-Specific Antigen (PSA) test. Unlike some other BPH medications, Terazosin does not artificially lower PSA levels, making it easier to monitor for prostate cancer.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter cold medicines which may contain vasoconstrictors that oppose Terazosin.
As mentioned, Terazosin belongs to the quinazoline class. If you have experienced hives, swelling, or difficulty breathing after taking Cardura (Doxazosin) or Minipress (Prazosin), you must notify your doctor, as Terazosin is likely to cause the same reaction.
> Important: Your healthcare provider will evaluate your complete medical history, including any previous reactions to medications, before prescribing Terazosin. Always disclose any history of heart valve disease or liver problems.
Terazosin is not approved for use in children. The pathophysiology of hypertension in children often differs from adults, and the safety of alpha-blockade in developing bodies has not been sufficiently studied. Conditions like BPH do not typically occur in the pediatric population.
Patients over the age of 65 represent a significant portion of Terazosin users, particularly for BPH.
In patients with impaired renal function, the pharmacokinetics of Terazosin are not significantly altered. The drug is not dialyzable because it is highly protein-bound. No specific dose adjustments are mandated for renal failure, but clinicians should monitor these patients for fluid retention.
Because the liver is the primary organ for Terazosin metabolism, patients with Child-Pugh Class B or C hepatic impairment should be monitored closely. There is no specific formula for dose reduction, but a 'start low, go slow' approach is essential to avoid accumulation and toxicity.
> Important: Special populations require individualized medical assessment. Always inform your doctor if you are pregnant, planning to become pregnant, or are breastfeeding.
| Parameter | Value |
|---|---|
| Bioavailability | ~90% |
| Protein Binding | 90% - 94% |
| Half-life | ~12 hours |
| Tmax (Time to peak) | 1 hour |
| Metabolism | Hepatic (Minimal CYP involvement) |
| Excretion | Biliary (60%), Renal (40%) |
Terazosin is classified as a selective alpha-1 adrenergic antagonist. It is part of the 'first-generation' of long-acting alpha-blockers. Unlike Tamsulosin (which is more selective for the alpha-1a subtype found in the prostate), Terazosin is non-subtype selective (affecting 1a, 1b, and 1d), which is why it is effective for both blood pressure and BPH.